Strata Critical Medical, Inc. (SRTA) intrinsic value & 10-year financials
Strata Critical Medical, Inc. (SRTA) has a Graham intrinsic value of $16.61 per share. At $4.54 on Oct 17, 2026, the stock trades 73% below that value. Over the last 8 fiscal years revenue grew 36.0% a year to $197.1M, with an average return on invested capital of 168.1%.
- Graham intrinsic value
- $16.61
- Share price (Oct 17, 2026)
- $4.54
- Price vs Graham value
- 73% below
- Market cap
- $372.7M
- Revenue (FY2025)
- $197.1M
- Revenue growth (8-yr CAGR)
- 36.0%
- ROIC (10-yr avg)
- 168.1%
- Free cash flow (FY2025)
- -$58.5M
SRTA 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $197.1M | $41.3M | $0.50 | -$58.5M | -11.3% | -9.7% |
| FY2024 | $248.7M | -$27.3M | -$0.35 | -$33.4M | -13.6% | -15.4% |
| FY2023 | $225.2M | -$56.1M | -$0.76 | -$34.5M | -30.3% | -28.1% |
| FY2022 | $146.1M | -$27.3M | -$0.38 | -$37.9M | -36.6% | -19.6% |
| FY2021 | $50.5M | -$40.1M | -$0.93 | -$15.9M | -47.7% | -15.6% |
| FY2020 | $23.4M | -$10.2M | -$0.40 | -$11.2M | -44.2% | 1309.6% |
| FY2019 | $31.2M | -$10.8M | -$0.43 | -$10.9M | -37.0% | -44.5% |
| FY2018 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Strata Critical Medical, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Strata Critical Medical, Inc. has historically struggled to out-earn its cost of capital, averaging just -17.1% ROIC.
Strata Critical Medical, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Strata Critical Medical, Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $16.61 per share.